insights_auto
Why is GH up 2,98%?
Dive Deeperchevron_right
GH:NASDAQ
Guardant Health Inc
162,59 USD
arrow_upward
+2,98%(+4,71) 1D
159,34 USD
arrow_downward
-2,00% (-3,25)bedtimeAfter hours
Closed: 20-окт., 16:00:01 GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for GH...
Open
158,29 USD
High
163,56 USD
Low
155,07 USD
Mkt. cap
21,82 млд
Avg. vol.
1,80 млн
Volume
0,00
52-wk high
191,01 USD
52-wk low
66,59 USD
EPS
-3,50 USD
Beta
1,58
Shares outstanding
134,20 млн
No. of employees
2 миң
Open
158,29 USD
High
163,56 USD
Low
155,07 USD
Mkt. cap
21,82 млд
Avg. vol.
1,80 млн
Volume
0,00
52-wk high
191,01 USD
52-wk low
66,59 USD
EPS
-3,50 USD
Beta
1,58
Shares outstanding
134,20 млн
No. of employees
2 миң
News stories
From web sources and news partners
Stock Titan
·
13 саат мурун
Five short talks will explore blood-based cancer tests at ESMO, among 25 studies from Guardant and collaborators.
Investing.com Canada
·
23 саат мурун
Guardant Health director Tariq Musa sells $19,242 in stock By Investing.com
Stocks Down Under
·
1 күн мурун
Guardant Health (NDQ:GH): The Company Betting Its Cancer Screening Method Will Be Revolutionary!
Seeking Alpha
·
1 күн мурун
Guardant Health: Growth Remains Too Expensive, Reiterate Hold (NASDAQ:GH)
Profile
Guardant Health, Inc. is an American biotechnology company based in Palo Alto, California. Co-founders Helmy Eltoukhy and AmirAli Talasaz serve as co-chief executive officers. Wikipedia
About Guardant Health Inc
CEOHelmy Eltoukhy | AmirAli Talasaz
Employees2,5 миң
Founded2012
HeadquartersПало Альто, Калифорния, Америка Кошмо Штаттары
SectorHealth care provider
Websiteguardanthealth.com